As of 2025-07-13, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 18.09 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.39 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 433.6%.
The range of the Relative Valuation is 12.11 - 30.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.5x - 39.8x | 26.8x |
| Forward P/E multiples | 25.1x - 47.6x | 32.4x |
| Fair Price | 12.11 - 30.52 | 18.09 |
| Upside | 257.3% - 800.3% | 433.6% |
| Date | P/E |
| 2025-07-11 | 4.42 |
| 2025-07-10 | 4.59 |
| 2025-07-09 | 4.69 |
| 2025-07-08 | 4.68 |
| 2025-07-07 | 4.62 |
| 2025-07-03 | 4.67 |
| 2025-07-02 | 4.64 |
| 2025-07-01 | 4.68 |
| 2025-06-30 | 4.47 |
| 2025-06-27 | 4.34 |
| 2025-06-26 | 4.32 |
| 2025-06-25 | 4.32 |
| 2025-06-24 | 4.38 |
| 2025-06-23 | 4.37 |
| 2025-06-20 | 4.17 |
| 2025-06-18 | 4.43 |
| 2025-06-17 | 4.47 |
| 2025-06-16 | 4.50 |
| 2025-06-13 | 4.37 |
| 2025-06-12 | 4.64 |
| 2025-06-11 | 4.62 |
| 2025-06-10 | 4.69 |
| 2025-06-09 | 4.69 |
| 2025-06-06 | 4.85 |
| 2025-06-05 | 4.76 |
| 2025-06-04 | 4.64 |
| 2025-06-03 | 4.32 |
| 2025-06-02 | 4.28 |
| 2025-05-30 | 4.28 |
| 2025-05-29 | 4.41 |
| 2025-05-28 | 4.39 |
| 2025-05-27 | 4.49 |
| 2025-05-23 | 4.22 |
| 2025-05-22 | 4.24 |
| 2025-05-21 | 4.37 |
| 2025-05-20 | 4.73 |
| 2025-05-19 | 4.67 |
| 2025-05-16 | 4.42 |
| 2025-05-15 | 4.28 |
| 2025-05-14 | 3.78 |
| 2025-05-13 | 3.93 |
| 2025-05-12 | 3.96 |
| 2025-05-09 | 3.79 |
| 2025-05-08 | 4.00 |
| 2025-05-07 | 3.90 |
| 2025-05-06 | 3.89 |
| 2025-05-05 | 4.00 |
| 2025-05-02 | 4.19 |
| 2025-05-01 | 4.02 |
| 2025-04-30 | 4.15 |